SANA AMLANI: Open Payments
NPI 1073102125 · NILES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 27 payments from 18 companies in 2025. Trend: 2023 $130 · 2024 $565 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $140 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Incyte Corporation | 4 | $98 |
| SpringWorks Therapeutics, Inc. | 1 | $76 |
| Agios Pharmaceuticals, Inc. | 2 | $61 |
| BeiGene USA, Inc. | 1 | $48 |
| Genentech USA, Inc. | 2 | $45 |
| PharmaEssentia USA Corporation | 1 | $36 |
| Celgene Corporation | 1 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
Products named: OJJAARA, OGSIVEO, JAKAFI, PYRUKYND, SCEMBLIX, BRUKINSA, Fabhalta, BESREMI.
Industry payments across IL — which companies pay providers there.
